Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Encho Savov is active.

Publication


Featured researches published by Encho Savov.


Microbial Drug Resistance | 2008

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Bulgarian Hospitals

Rumyana Markovska; Ines Schneider; Emma Keuleyan; Mariya Sredkova; Dobrinka Ivanova; Boyka Markova; Grozdanka Lazarova; Elisaveta Dragijeva; Encho Savov; Irina Haydouchka; Nasya Hadjieva; Lena Setchanova; Ivan Mitov; Adolf Bauernfeind

The aim of the study was to describe the emergence, the spread, and the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria. Over eight years (1996-2003), 442 ESBL-screen-positive isolates were collected in nine medical institutions in four Bulgarian towns. Class A ESBLs of the SHV, TEM, and CTX-M groups were identified in seven species. SHV-type enzymes persisted during the whole study period, TEM-ESBLs appeared first in 1999, and CTX-M-types appeared first in 2001. The rate of CTX-M enzyme producers increased rapidly between 2001 and 2003, while the rate of SHV producers decreased. Six different ESBL-types were identified, namely, SHV-2, -5, and -12, CTX-M-3 and -15, and a new TEM-3-like variant (TEM-139). The most widespread enzymes were SHV-12, CTX-M-15, and CTX-M-3 found in seven centers. TEM-139 was identified mainly in one center. A trend for strains harboring more than one ESBL gene, for example, CTX-M + SHV, was observed since 2002. Plasmid fingerprinting and random amplified polymorphic DNA analysis typing revealed wide dissemination of identical plasmids among different bacterial species and hospitals, as well as clonal spread of ESBL producers. Our data contribute to clarify the dynamics in the prevalence of ESBLs in Bulgaria and demonstrate the importance of molecular procedures for their analysis.


Antimicrobial Agents and Chemotherapy | 2014

Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in Bulgaria

Laurent Poirel; Encho Savov; Arzu Nazli; Angelina Trifonova; Iva Todorova; Ivanka Gergova; Patrice Nordmann

ABSTRACT Twelve consecutive carbapenem-resistant Escherichia coli isolates were recovered from patients (infection or colonization) hospitalized between March and September 2012 in different units at a hospital in Bulgaria. They all produced the carbapenemase NDM-1 and the extended-spectrum-β-lactamase CTX-M-15, together with the 16S rRNA methylase RmtB, conferring high-level resistance to all aminoglycosides. All those isolates were clonally related and belonged to the same sequence type, ST101. In addition to being the first to identify NDM-producing isolates in Bulgaria, this is the very first study reporting an outbreak of NDM-1-producing E. coli in the world.


Brazilian Journal of Infectious Diseases | 2016

Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria

Tanya Strateva; Daniela Atanasova; Encho Savov; Guergana Petrova; Ivan Mitov

OBJECTIVES To evaluate the prevalence of some virulence genes among 510 clinical Enterococcus spp. isolates and to assess the association of those genes with the species, infection site, and patient group (inpatients/outpatients). METHODS Adhesins genes (aggregation substances agg and asa1 of Enterococcus faecalis and Enterococcus faecium, respectively), enterococcal surface protein (esp), endocarditis-specific antigen A (efaA), collagen-binding proteins (ace/acm)); invasins (hyaluronidase (hyl) and gelatinase (gelE)); cytotoxines (activation of cytolysin (cylA) in E. faecalis); and modulators of the host immunity and inflammation (enhanced expression pheromone (eep) in E. faecalis) were detected by polymerase chain reaction. RESULTS The overall prevalence was: esp - 44.3%, agg/asa1 - 38.4%, ace/acm - 64.3%, efaA - 85.9%, eep - 69.4%, gelE - 64.3%, hyl - 25.1%, and cylA - 47.1%. E. faecalis isolates had significantly higher frequency of adhesin genes (esp and agg/asa1) and gelatinase in comparison to E. faecium. Multiple virulence genes in E. faecalis were significantly more prevalent than in E. faecium isolates. Domination of E. faecium with or without only one gene compared to the isolates of E. faecalis were found. Enterococcus spp. isolates obtained from outpatients compared to inpatients isolates had significantly higher frequency of agg/asa1, eep, gelE and cylA. Some adhesins genes (esp, agg/asa1 and efaA) had higher prevalence among the non-invasive Enterococcus spp. isolates compared to those causing invasive bacteremia, while ace/acm revealed higher dissemination in isolates causing invasive infections compared to non-invasive isolates. CONCLUSION Most E. faecalis attaches to abiotic surfaces in hospital environment, which correlates with higher prevalence of gene encoding for virulence factors involved in biofilm formation, such as enterococcal surface protein, aggregation substance, and gelatinase. The intestinal tract is an important reservoir for opportunistic enterococcal pathogens and allows them to access infectious sites through different virulence factors, demonstrated in outpatient isolates in this study.


Journal of Microbiological Methods | 2011

Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates.

Yann Deccache; Léonid M. Irenge; Encho Savov; Mihaela Ariciuc; Alexandra Macovei; Angelina Trifonova; Ivanka Gergova; Jérôme Ambroise; Raymond Vanhoof; Jean-Luc Gala

Rapid and reliable assessment of Acinetobacter baumannii resistance to quinolones was successfully achieved through pyrosequencing of the gyrA and parC quinolone-resistance determining regions. A strong correlation was found between quinolone resistance and mutations in gyrA codon 83 and/or in the parC gene (codons 80 or 84). Absence of QRDR mutations was associated with susceptibility to quinolones.


Journal of global antimicrobial resistance | 2016

Isolation of Acinetobacter radioresistens from a clinical sample in Bulgaria

Encho Savov; Yvonne Pfeifer; Gottfried Wilharm; Angelina Trifonova; Iva Todorova; Ivanka Gergova; Maja Borisova; Elena Kjoseva

We report on the role of Acinetobacter radioresistens in a case of pneumonia in an elderly patient and describe the challenge of correct identification of this species. A tracheobronchial culture taken from a patient in a Bulgarian hospital yielded a pure culture of Gram-negative, lactose-non-fermenting bacilli on MacConkey agar. Genus and species identification was performed by biochemical tests and sequencing of the rpoB gene. Antimicrobial susceptibility testing and screening for blaOXA-like carbapenemase genes was done using microbroth dilution and PCR and sequencing, respectively. The bacillus growing on MacConkey agar was initially identified by biochemical tests as Acinetobacter baumannii complex. Sequencing of the rpoB gene finally identified A. radioresistens. The strain harboured the carbapenemase gene blaOXA-23 without insertion sequences upstream of this gene and was susceptible to imipenem and meropenem. In conclusion, detection of A. radioresistens remains a challenge for routine laboratory diagnostics without performance of molecular identification methods. Although A. radioresistens can be a causative agent of opportunistic infections, in the present case its involvement in the development of pneumonia is doubtful.


Archive | 2009

Multidrug-Resistant Acinetobacter Baumannii: A Major Threat Worldwide

Encho Savov; G. Mihaylova; Maja Borisova; Temenuga Stoeva; E. Kjoseva; Angelina Trifonova

Historically, Acinetobacter spp have been associated at the beginning of 70 with opportunistic infections that were rare and modest severity. The last 3 decades have seen an increase in both the incidence and seriousness of Acinetobacters, especially of A. baumannii infections. There is an indication of an increase also in the number of reported A. baumannii bloodstream infections and very seriously wound infection in patients at military medical facilities in Iraq, Kuwait and Afganistan. Together with this fact, A. baumannii infections became very important because of concomitant development of resistance and multiresistance of the strains to antimicrobial drugs with high rates. This paper reflects the problem A. baumannii infections of the literature’ background and own data, their clonal spread significance and multidtug/pandrug’/resistance threat worldwide.


Chemotherapy | 2017

Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria

Encho Savov; Iva Todorova; Lida Politi; Angelina Trifonova; Maja Borisova; Elena Kioseva; Athanassios Tsakris

Background/Aims: Colistin resistance is increasingly recognized among carbapenemase-producing Klebsiella pneumoniae isolates in several European regions. The current study documents the appearance of colistin resistance among KPC-2 and SHV-5-produning K. pneumoniae strains in Bulgaria. Methods: Four colistin-resistant K. pneumoniae isolates were recovered from 2 patients hospitalized in the anesthesiology and resuscitation clinic of a tertiary care university hospital in Sofia, Bulgaria. Microbial identification and antimicrobial susceptibility testing was performed by Vitek 2 (Biomerieux, France). β-Lactamase genes were amplified using a panel of primers for detection of all MBL-types, KPCs, plasmid-mediated AmpCs in single PCR reactions, OXA-type carbapenemases, extended-spectrum β-lactamases (ESBLs) and TEM enzymes. The colistin-resistant mcr-1 gene was also investigated using previously described primers and conditions. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used to investigate clonality. Results: The 4 K. pneumoniae isolates exhibited colistin MICs >16 mg/L and showed multidrug-resistant phenotypes, remaining intermediately susceptible only to gentamicin. They were clustered into a single PFGE clonal type and MLST assigned them to sequence type 258. All isolates possessed KPC-2 carbapenemase and SHV-5 ESBL. They were negative for the plasmid-mediated colistin-resistant mcr-1 gene, possibly implying an intrinsic mechanism of resistance. Conclusions: Although colistin use in Bulgaria only started moderately during 2014, the findings of the current study notify the appearance of colistin resistance among carbapenemase-producing Klebsiella species in another European region.


Infectious diseases | 2018

Clonal spread of vanA Enterococcus faecium sequence type 203 in Bulgarian hospitals

Tanya Strateva; Ivo Sirakov; S. Dimov; Angelina Trifonova; Encho Savov; Ivan Mitov

Sir,Enterococci are generally low-virulent, but can cause serious infections in immunocompromised patients. Clonal spread of vancomycin-susceptible Enterococcus faecium at an adult haematology ward...


Journal of Antimicrobial Chemotherapy | 2009

Nosocomial spread of OXA-23 and OXA-58 β-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital

Temenuga Stoeva; Paul G. Higgins; Encho Savov; Rumyana Markovska; Ivan Mitov; Harald Seifert


Bioinformatics | 2014

Amplicon identification using SparsE representation of multiplex PYROsequencing signal (AdvISER-M-PYRO): application to bacterial resistance genotyping

Jérôme Ambroise; Yann Deccache; Léonid M. Irenge; Encho Savov; Annie Robert; Jean-Luc Gala

Collaboration


Dive into the Encho Savov's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Iva Todorova

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Ivanka Gergova

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Maja Borisova

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Jean-Luc Gala

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Jérôme Ambroise

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Léonid M. Irenge

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Yann Deccache

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Temenuga Stoeva

Medical University of Varna

View shared research outputs
Researchain Logo
Decentralizing Knowledge